rs113091974

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001191061.2(SLC25A22):​c.412+10G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00779 in 1,449,026 control chromosomes in the GnomAD database, including 656 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.037 ( 343 hom., cov: 31)
Exomes 𝑓: 0.0044 ( 313 hom. )

Consequence

SLC25A22
NM_001191061.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.38

Publications

1 publications found
Variant links:
Genes affected
SLC25A22 (HGNC:19954): (solute carrier family 25 member 22) This gene encodes a mitochondrial glutamate carrier. Mutations in this gene are associated with early infantile epileptic encephalopathy. Multiple alternatively spliced variants, encoding the same protein, have been identified.[provided by RefSeq, Jul 2010]
SLC25A22 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • developmental and epileptic encephalopathy, 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • early myoclonic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 11-792860-C-A is Benign according to our data. Variant chr11-792860-C-A is described in ClinVar as Benign. ClinVar VariationId is 159915.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.124 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC25A22NM_001191061.2 linkc.412+10G>T intron_variant Intron 6 of 9 ENST00000628067.3 NP_001177990.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC25A22ENST00000628067.3 linkc.412+10G>T intron_variant Intron 6 of 9 1 NM_001191061.2 ENSP00000486058.1

Frequencies

GnomAD3 genomes
AF:
0.0368
AC:
5572
AN:
151390
Hom.:
340
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.127
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0152
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.000209
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0159
Gnomad NFE
AF:
0.000428
Gnomad OTH
AF:
0.0284
GnomAD2 exomes
AF:
0.00983
AC:
2383
AN:
242430
AF XY:
0.00738
show subpopulations
Gnomad AFR exome
AF:
0.132
Gnomad AMR exome
AF:
0.00752
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000403
Gnomad OTH exome
AF:
0.00589
GnomAD4 exome
AF:
0.00441
AC:
5719
AN:
1297516
Hom.:
313
Cov.:
38
AF XY:
0.00384
AC XY:
2503
AN XY:
651356
show subpopulations
African (AFR)
AF:
0.144
AC:
4489
AN:
31068
American (AMR)
AF:
0.00884
AC:
391
AN:
44236
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24922
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38570
South Asian (SAS)
AF:
0.000363
AC:
30
AN:
82540
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49192
Middle Eastern (MID)
AF:
0.00892
AC:
49
AN:
5492
European-Non Finnish (NFE)
AF:
0.000228
AC:
220
AN:
966452
Other (OTH)
AF:
0.00981
AC:
540
AN:
55044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.569
Heterozygous variant carriers
0
294
588
883
1177
1471
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
142
284
426
568
710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0368
AC:
5576
AN:
151510
Hom.:
343
Cov.:
31
AF XY:
0.0350
AC XY:
2589
AN XY:
74064
show subpopulations
African (AFR)
AF:
0.127
AC:
5250
AN:
41296
American (AMR)
AF:
0.0152
AC:
232
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000195
AC:
1
AN:
5134
South Asian (SAS)
AF:
0.000209
AC:
1
AN:
4786
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10518
Middle Eastern (MID)
AF:
0.0137
AC:
4
AN:
292
European-Non Finnish (NFE)
AF:
0.000428
AC:
29
AN:
67748
Other (OTH)
AF:
0.0281
AC:
59
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.547
Heterozygous variant carriers
0
234
469
703
938
1172
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0165
Hom.:
46
Bravo
AF:
0.0422
Asia WGS
AF:
0.00779
AC:
27
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Developmental and epileptic encephalopathy Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Developmental and epileptic encephalopathy, 3 Benign:1
Sep 17, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Early myoclonic encephalopathy Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.0020
DANN
Benign
0.66
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113091974; hg19: chr11-792860; API